SGLT2 Inhibitors: Selecting the Right Agent Within the Class
Evidence-based guide to choosing between empagliflozin, dapagliflozin, canagliflozin, ertugliflozin, and sotagliflozin based on indication, trial data, renal function, and formulary access.
Read clinical review